enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. GSK plc - Wikipedia

    en.wikipedia.org/wiki/GSK_plc

    GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

  3. GSK shares fall after sales of top two vaccines disappoint - AOL

    www.aol.com/news/gsk-raises-annual-profit-sales...

    GSK would share additional data with U.S. agencies by the end of this year, she said. Citing the U.S. agency's decision, GSK cut its forecast for 2024 vaccine sales.

  4. GSK raises full-year profit forecast, says first-half will ...

    www.aol.com/news/gsk-raises-full-profit-forecast...

    The London-listed drugmaker said it now expects a rise of 8% to 10% in annual adjusted earnings per share, up from the 6%-9% growth previously forecast. It also expects its 2024 sales to rise in ...

  5. Haleon - Wikipedia

    en.wikipedia.org/wiki/Haleon

    Unilever offered £50 billion for the business in 2022, in a bid which GSK rejected. [11] Nestlé examined the possibility of a bid in conjunction with Reckitt. [12] In October 2023, GSK reduced its ownership share in Haleon to just over 7.4%, [13] and again in January 2024 down to 4.2%. [14]

  6. Sanofi–GSK COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Sanofi–GSK_COVID-19_vaccine

    The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [8][9]

  7. GSK CEO says RSV vaccine revenue to top 1 billion pounds in ...

    www.aol.com/news/gsk-ceo-says-rsv-vaccine...

    The U.S. Food and Drug Administration (FDA) approved Arexvy for adults aged 60 years or older in May and GSK launched the vaccine in the U.S. later in the year. It is also approved in Europe ...

  8. Emma Walmsley - Wikipedia

    en.wikipedia.org/wiki/Emma_Walmsley

    Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GlaxoSmithKline. [1] She succeeded Sir Andrew Witty, who retired in March 2017. [2] Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. [3] She grew up in Barrow-in-Furness, Cumbria, England.

  9. Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.